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The relation between preoperative left ventricular muscle 
mass and clinical outcome of the Fontan procedure was 
evaluated retrospectively in 22 patients with tricuspid 
atresia who were selected for this physiologic surgical 
correction by conventional hemodynamic criteria. Patients 
were divided into two groups: group A (excellent or good 
outcome) and group B (poor outcome or death) based on 
the clinical course assessed up to 9.5 years postoperatively. 
Thirteen of 22 group A patients did not have prolonged, 
clinically sign&ant, systemic venous hypertension and 
were not on long-term diuretic drug therapy. Nine of 22 
group B patients either had clinically significant systemic 
venous hypertension, required long-term diuretic drug 
therapy or died (3 patients). Age at surgery, pulmonary 
arteriolar resistance, left ventricular ejection fraction, end- 
diastolic volume, end-diastolic pressure, systemic oxygen 
saturation and pulmonary to systemic blood flow ratio 
(Qp/Qs) were not statistically different between the two 
groups. Left ventricular muscle mass, both in group A 
patients (92 f 31 g/m*) and in group B patients (146 f 61 
For patients with tricuspid atresia considered as candidates 
for the surgical Fontan procedure, selection criteria based on 
clinical and hemodynamic variables have been proposed and 
extensively reviewed (l-11). For these patients to benefit 
from the Fontan procedure and its variants, they must have 
satisfactory systolic and diastolic left ventricular function. 
Left ventricular dysfunction is known to occur in some of 
these patients before the Fontan procedure, and it may not 
always be reversible after relief of the chronic volume 
overload and cyanosis (10-15). The role of left ventricular 
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g/m*), was greater than the normal mean value (p < 0.01 
and p < 0.001, respectively). 
Left ventricular muscle mass in group B was signifi- 
cantly greater than in group A (p < 0.01). Furthermore, 
left ventricular muscle masslend-diastolic volume (massf 
volume) ratio, reflecting the extent of left ventricular hy- 
per-trophy relative to vohtme overload, was significantly 
greater in group B (1.1 f 0.28) than in group A (0.84 + 
0.21) (p < 0.05). These- findings are consistent with the 
observation that less satisfactory postoperative clinical out- 
come may, at least in part, be related to impaired diastolic 
function associated with inappropriately hypertrophied left 
ventricular myocardium. 
Determination of left ventricular muscle mass appears 
to be a useful variable to be considered along with conven- 
tional hemodynamic selection criteria for anticipating the 
clinical outcome ln patients with tricuspid atresia consid- 
ered as candidates for the Fontan procedure. 
(J Am Call CardiolI989;14:750-5) 
pressure, volume and ejection fraction in the outcome of the 
Fontan procedure has been previously evaluated (9-15). 
Because the left ventricle in tricuspid atresia is the 
principal pump supporting both systemic and pulmonary 
circulation, left ventricular muscle mass is expected to be 
increased. We hypothesized that an excessive increase in 
left ventricular muscle mass may have a deleterious effect on 
outcome of the Fontan procedure. This study is a retrospec- 
tive analysis of the relation of left ventricular myocardial 
hypertrophy (measured as left ventricular muscle mass) to 
early and late postoperative clinical outcome. 
Methods 
Patient selection. Preoperative cardiac catheterization 
and clinical records were examined retrospectively in 50 
patients with tricuspid atresia undergoing the Fontan proce- 
dure between 1978 and 1987. Twenty-two patients were 
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selected for this study based on availability of both good 
quality left ventricular cineangiograms and complete hemo- 
dynamic data. The mean age at surgery was 7.6 years (range 
0.8 to 19.8) and the mean interval between preoperative 
catheterization and surgery was 5 months (range I to 16). 
The majority of patients (17 of 22) had normally related great 
arteries and 15 had decreased pulmonary blood flow at initial 
evaluation (16,17). The mean postoperative follow-up inter- 
val was 6.4 years (range 1.6 to 9.5). 
SurgIeal procedures. Eighteen patients underwent a total 
of 31 prior palliative surgical procedures. These included 
systemic to pulmonary arterial shunts in 18 patients at a 
mean age of 2.89 years (range 3 days to 14 years), Glenn 
anastomoses in 6 patients at a mean age of 6.26 years (range 
0.6 to 14), pulmonary artery banding in 3 patients between 
birth and 5 months of age, atria1 septostomy in 3 patients and 
pulmonary valvotomy in 1 patient. All shunts were function- 
ing at time of the Fontan procedure, except in one patient. 
Four patients had no prior palliative procedure. 
A modified version of the Fontan procedure was per- 
formed in our patients (8,18-21). No prosthetic valve was 
used in 9 of the 11 atriopulmonary anastomoses. Eleven 
prosthetic valves were used in 11 of 14 patients who had 
incorporation of a portion of the right ventricle in the 
procedure (five in the pulmonary valve position and six in 
the tricuspid valve position). 
Hemodynamic and angiocardiographic procedures. In- 
formed consent to the procedure was obtained from all 
patients, their parents or legal guardians. All patients under- 
went cardiac catheterization and selective left ventricular 
angiography under sedation with fentanyl citrateidroperidol 
(Innovar) (0.04 ml/kg, intramuscularly) and promethazine (1 
mglkg, intramuscularly). All patients were in normal sinus 
rhythm at the time of cardiac catheterization. 
Right atrial, pulmonary artery, left ventricular and aortic 
pressures were obtained. Pulmonary venous wedge pressure 
was used when the pulmonary arteries could not be entered. 
Pulmonary and systemic flow indexes were calculated by the 
Fick method using measured oxygen consumption and ex- 
pressed in liters/min per m2. Pulmonary and systemic vas- 
cular resistances were calculated and expressed in Wood 
units. 
Cine frames exposed in proximity to premature ventric- 
ular contractions were excluded. The left ventricular cavity 
was traced manually at both end-diastole and end-systole 
from left ventricular biplane cineangiograms in posteroante- 
rior and lateral projections. Left ventricular end-systolic and 
end-diastolic volumes as well as left ventricular ejection 
fraction were calculated as described by Lange et al. (22) and 
processed with a digitizer (Summagraphics MM 1200) con- 
nected to a computer (Alpha Micro AM 100/L). 
Left ventricular mass calculation. Left ventricular wall 
thickness at end-diastole was measured as described by 
Rackley et al. (23) and added uniformly as an outside shell to 
Table 1. Left Ventricular Volume and Mass Data in Normal 
Infants and Children 
No. of LVMM LVEDV 
Study Cases Wm? (ml/m’) M/V 
Graham et al. (24) 34 86t 11 73* 11 1.18 
Onnasch et al. (25) 28 67.8 r 13.8 64 + 10.8 1.01 t 0.14 
Nakano (26) 15 66 c 17 68 f 14 0.98 + 0.15 
Present study 9 602.5 59 ? 6.4 1.03 + 0.18 
LVEDV = left ventricular end-diastolic volume; LVMM = left ventricu- 
lar muscle mass; M/V = left ventricular muscle mass/end-diastolic volume 
ratio. 
the left ventricular end-diastolic cavity volume tracing to 
obtain the total left ventricular cavity plus myocardial vol- 
ume. The volume of the left ventricular myocardium was 
calculated as the difference between total left ventricular 
volume and left ventricular end-diastolic volume and multi- 
plied by 1.05 (specific gravity of the myocardium) to provide 
left ventricular muscle mass expressed as g/m2. 
Two observers calculated left ventricular muscle mass 
independently to assess the interobserver and intraobserver 
variability, which were found to be insignificant (left ventric- 
ular wall thickness 7.9 + 2.92 [first observer] versus 8.1 f 
2.49 mm [second observer] and 8 + 2.52 [first occasion] 
versus 7.9 I 2.92 mm [second occasion]). 
Left ventricular muscle mass: control group and normal 
values. Left ventricular muscle mass was calculated using 
the same method from left ventricular cineangiograms of 
nine control patients (mean age 4.8 years) who underwent 
cardiac catheterization and were found to have hemodynam- 
ically insignificant lesions not affecting left ventricular vol- 
ume and pressure variables. Three patients had trivial pul- 
monary stenosis (pressure gradient < 30 mm Hg), three had 
a small secondum atrial septal defect (QplQs < 1 S), one had 
syncope, one had lung disease and one had mitral valve 
prolapse without mitral insufficiency. In this group, left 
ventricular muscle mass was 60 + 5.1 g/m2, left ventricular 
end-diastolic volume was 59 f 6.4 ml/m2 and mass/volume 
ratio was 1.03 ? 0.18. 
Several studies (24-26) are available on left ventricular 
volume/mass variables in normal infants and children. Be- 
cause of the close correlation between the values obtained in 
our small control group (n = 9) and those reported by 
Onnasch et al. (25) and Nakano (26), we used the values of 
Onnasch et al. as a reference for normal left ventricular 
volume/mass variables (Table 1). 
Postoperative clinical assessment. A grading scale for 
postoperative outcome was developed on the basis of objec- 
tive clinical manifestations of systemic venous hypertension 
and the need for long-term diuretic drug therapy beyond 1 
year after the Fontan procedure and up to the most recent 
clinical examination (Table 2). Group A included 13 patients 
with excellent or good clinical outcome, and Group B 
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Table 2. Clinical Assessment of the Fontan Procedure Outcome in 
22 Patients 
Clinical Outcome 
Group A 
Excellent Good 
(n = 5) (n = 8) 
Group B 
Poor Death 
(n = 6) (n = 3) 
Systemic venous 
hypertension 
Peripheral edema 
As&es 
Pericardial or pleural 
effusions 
Varicose veins 
Hepatomegaly 
Diuretic drug therapy 
Death from 
hemodynamic failure 
+ +t ttt ttt 
_ 
_ 
_ 
_ _ 
t tt 
Intermittent 
short-term 
(~6 
months) 
_ 
tt/ttt 
tt/ttt 
ttittt 
tt/ttt 
ttt 
Continuous Continuous 
long-term long-term 
(>6 
months) 
Yes* 
*Two patients died in the immed@e postoperative period and the third 
died within 6 months. All had severe systemic venous hypertension before 
death. - = none; t = mild; t t = moderate; t t t = severe. 
included 9 patients with poor outcome or death because of 
hemodynamic failure. 
Statistical analysis. All data are expressed as mean * 
standard deviation. An unpaired two-tailed f-test and chi- 
square analysis were used for comparison between the 
groups, with probability (p) value ~0.05 being statistically 
significant. 
Results 
Preoperative hemodynamic data (Table 3). All patients 
were considered suitable candidates for the Fontan proce- 
dure based on their preoperative hemodynamic data and 
other conventional selection criteria. Normal sinus rhythm, 
competent mitral valve, a functioning palliative shunt and 
normal drainage of venae cavae were present in all patients. 
A peak systolic pressure gradient of 10 mm Hg between the 
left ventricle and ascending aorta was present in one patient. 
Left ventricular muscle mass for the entire group (114 5 52 
g/m*) was significantly greater than normal (p < 0.001). 
Group A (Table 4). Thirteen patients had an excellent or 
good outcome. Left ventricular muscle mass in this group 
ranged from 62 to 182 g/m’ (mean 92 ? 3 1) g and was greater 
than normal (p < 0.01); however, 9 of the 13 had a left 
ventricular muscle mass 12 standard deviations of the 
normal mean value (Fig. 1). Left ventricular end-diastolic 
volume in this group ranged from 69 to 210 ml/m’ (mean 
115 f 40) and was also greater than normal ( p < 0.001). The 
mass/volume ratio ranged from 0.5 to 1.3 (mean 0.84 ? 0.21), 
which was significantly smaller than normal (p < 0.01). 
Table 3. Preoperative Hemodynamic Data for the Entire Study 
Group of 22 Patients 
Mean Range 
Conventional 
Selection 
Criteria p Value* 
Age (yr) 7.61 0.8 to 19.83 4 to 15 
RAiii 7.1 2to 12 
PA iii 16.3 7 to 40 Cl5 
PVR I .49 0.6 to 2.5 14 
LVEDV 123 69 to 210 <O.OOl 
LVEF 0.69 0.57 to 0.77 >0.6 
LVEDP 9 sto 15 
LVMM 114 62 to 298 <O.OOl 
LVWTH 6.9 4.1 to 10.5 
M/V 0.89 0.52 to 1.54 NS 
QP~Qs 1.9 0.8 to 4. I 
SVR 18.3 II to 30 
Oxygen sat 84 72 to 91 
*Compared with normal. LVEDP = left ventricular end-dmstolic pressure 
(mm Hg); LVEDV = left ventricular end-diastolic volume (mUm*): LVEF = 
left ventricular ejection fraction: LVMM = left ventricular muscle mass 
(gIm’); LVWTH = left ventricular wall thickness (mm); MN = left ventric- 
ular muscle mass/end-diastolic volume ratio; Oxygen sat = oxygen saturation 
(%); PA iii = pulmonary artery mean pressure (mm Hg); PVR = pulmonary 
vascular resistance (units): Qp = pulmonary blood flow index; Qs = systemic 
blood flow index; R4 iii = right atrial mean pressure (mm Hg); SVR = 
systemic vascular resistance (units). 
Group B (Table 4). Nine patients had a poor outcome 
(n = 6) or died (n = 3). Two patients died in the early 
postoperative period from severe heart failure and low 
cardiac output (takedown of the Fontan anastomosis was 
unsuccessful in both patients) and one patient died 9 months 
postoperatively with severe systemic venous hypertension 
and congestive heart failure 3 months after the Fontan 
anastomosis was taken down. Left ventricular muscle mass 
in this group ranged from 78 to 298 g/m’ (mean 146 f 61) and 
was significantly greater than in the normal patients and 
group A patients (p < 0.001 and p < 0.001, respectively). 
Table 4. Preoperative Hemodynamic Data in 22 Patients 
Group A 
(n = 13) 
Group B 
(n = 9) p value 
Age at surgery (yr) 6.6 + 3.9 9.0 + 7.3 
RAZ 6.8 ? 2.1 8.9 + 2.4 
PAiii 14.7 t 8.2 18.7 f 5.8 
PVR 1.3 2 0.6 1.7 * 0.7 
LVEDV 115 + 40 134 + 33 
LVEF 0.68 r 0.056 0.71 + 0.057 
LVEDP 8.7 ? 3.4 10.0 f 2.8 
LVMM 92 ? 31 146 + 61 
LVWTH 5.9 + 1.6 8.3 ? 2.3 
M/V 0.84 ? 0.21 1.10 * 0.28 
Qp/Qs 2.1 + 1.2 1.7 i- 0.87 
Oxygen sat 84.7 + 4.9 83.7 ~5.5 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
<O.OOl 
<o.os 
<o.os 
NS 
NS 
Abbreviations as in Table 3. 
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Figure 1. Left ventricular muscle mass (LVM) in 13 8 
patients in group A and 9 patients in group B. A = 
group A; B = group B; M = mean; SD = standard 
5 
deviation for left ventricular muscle mass in normal 
ti 
infants and children (25). 
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Left ventricular muscle mass in 8 of the 9 patients was >2 
standard deviations above the normal mean value (Fig. 1). 
Left ventricular end-diastolic volume ranged from 97 to 194 
ml/m* (mean 134 ? 33) and was greater than normal (p < 
O.OOl), but not different from that in group A. The mass/ 
volume ratio ranged from 0.7 to 1.5 (mean 1.1 * 0.28) and 
was not different from normal, but was significantly greater 
than in group A (p < 0.05). Age at surgery, pulmonary 
arteriolar resistance, left ventricular ejection fraction. left 
ventricular end-diastolic volume and pressure. systemic 
oxygen saturation and pulmonary/systemic blood flow ratio 
were not significantly different in the two groups (Table 4). 
Modification of atriopulmonary anastomoses, a previous 
palliative procedure and anatomic types of tricuspid atresia 
present showed no statistically significant differences by 
chi-square analysis among these subgroups within both 
groups A and B. 
Discussion 
This retrospective study confirms the clinical observation 
that left ventricular muscle mass is increased in most pa- 
tients with tricuspid atresia. Based on the clinical outcome 
after the Fontan procedure, this study demonstrates that 
excessive left ventricular muscle mass (as in Group B 
patients) was associated with poorer outcome or death 
mainly as a result of decreased left ventricular compliance 
and diastolic dysfunction because other preoperative hemo- 
dynamic variables were similar in both good outcome and 
poor outcome patients. 
Response of left ventricular overload in tricuspid atresia: 
appropriate versus inappropriate hypertrophy. In most pa- 
tients with tricuspid atresia, the left ventricle is exposed to a 
large volume overload. Hence, it becomes both dilated with 
increased left ventricular end-diastolic volume (10,l 1 ,13-l 5) 
and hypertrophied with increased muscle mass (27-31) to 
M ??2SD LVM (g/m21 
meet its work load. This can be further increased by creation 
of palliative systemic to pulmonary shunts. Left ventricular 
dilation and hypertrophy were found in all patients in this 
study (Tables 3 and 4). The degree of left ventricular 
hypertrophy, however, may be appropriate (or physiologic) 
or inappropriate (32,33). Inappropriate hypertrophy indi- 
cates the presence of muscle mass in excess of that required 
for the work load. 
The patients with an excellent or good outcome appear to 
have had an appropriate degree of left ventricular kypertro- 
pky. Their cardiac muscle hypertrophied to match the im- 
posed volume overload, but within a physiologic range. Left 
ventricular muscle mass, although greater than normal. was 
52 standard deviations of the normal mean value in 8 of 13 
patients (Fig. 1). The mass/volume ratio, reflecting the 
extent of left ventricular hypertrophy relative to the in- 
creased left ventricular end-diastolic volume, was signifi- 
cantly smaller than normal (~1 in 1 I of 13 patients). This 
suggests that a lesser degree of hypertrophy may be appro- 
priate for the dilated left ventricle in patients with tricuspid 
atresia undergoing the Fontan procedure. 
The patient3 in the poor outcome/death group may have 
had an inappropriate degree of left ventricular kypertropky, 
with the left ventricular muscle mass significantly greater than 
that of both normal and group A patients. In eight of the nine 
patients, left ventricular muscle mass was >2 standard devi- 
ations above the normal mean value (Fig. 1). The mass/ 
volume ratio was significantly greater than that in group A and 
was >l in six of nine patients. This suggests that excessive 
hypertrophy of the dilated left ventricle is associated with the 
less favorable outcome after the Fontan procedure. 
The absence of a peak systolic pressure difference be- 
tween the left ventricle and aorta and the normal systemic 
vascular resistance in both groups exclude increased after- 
load as a contributing factor for excessive left ventricular 
hypertrophy in these patients. 
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Clinical sIgnIIcance of the degree of left ventricular hy- 
pet-trophy in patients with tricuspid atresia. Several studies 
(11,14,15) indicated that left ventricular muscle mass is sig- 
nificantly increased both in patients undergoing a palliative 
procedure and in patients having the Fontan procedure. 
Kirklin et al. (9), using a clinical and surgical estimate of left 
ventricular hypertrophy, inferred that the impaired diastolic 
function associated with an excessively hypertrophied ventri- 
cle is related to less satisfactory clinical results. The present 
study specifically quantitates the extent of left ventricular 
hypertrophy and correlates these findings with the postoper- 
ative clinical course over a period of 9.5 years. An increased 
risk of poor outcome or death after the Fontan procedure may 
be related to suboptimal perfusion of the subendocardium in 
the markedly hypertrophied ventricle. More extensive evalu- 
ation of left ventricular systolic and diastolic functional vari- 
ables including muscle mass may be useful in the preoperative 
assessment of these patients. To date, efforts are directed 
toward using smaller palliative shunts and early physiologic 
repair when feasible to minimize the progressive deleterious 
changes in left ventricular myocardium. 
Left ventricular dysfunction in tricuspid atresia. Although 
left ventricular dysfunction in tricuspid atresia has been 
documented in several studies (P-15), controversy remains 
regarding the precise mechanism responsible for impaired 
left ventricular function. Some studies suggest that long- 
standing volume overload (I 1,13,15) and hypoxemia ( 14) are 
the main factors involved. Our study and others (10) do not 
support this mechanism as the only explanation for reduced 
left ventricular function in some of these patients. We did 
not find a significant difference in loading conditions and 
oxygen saturation before the Fontan procedure between the 
good outcome and poor outcome groups. Other factors likely 
to play a role include left atrioventricular valve dysfunction 
(9), intraoperative impairment of the myocardium and long- 
standing elevated coronary venous pressure (12), arrhyth- 
mias and inappropriately hypertrophied left ventricular myo- 
cardium with abnormal diastolic compliance (9). 
In patients with tricuspid atresia, left ventricular dysfunc- 
tion, both systolic and diastolic, appears to be multifactorial. 
More prospective studies are needed to clarify the precise 
role of these factors in determining the outcome after the 
Fontan procedure. 
We thank Shann Bulger for assistance in preparation of the manuscript. 
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